Antiphospholipid syndrome (APLS) is a rare syndrome mainly characterized by several
hyper-coagulable complications and therefore, implicated in the operated cardiac surgery patient…

… Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL) (lupus anticoagulant, anticardiolipin antibodies and …

… Impaired ankle-brachial index in antiphospholipid syndrome: Beyond the traditional risk …
syndrome score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid …

… Antiphospholipid syndrome (APS) is an autoimmune systemic disease characterized by
a hypercoagulable state secondary to the presence of antiphospholipid antibodies and …

The prevalence of cardiovascular disease (CVD) in antiphospholipid syndrome (APS)
varies from one series to another depending on the definition of CVD and tools used for its …

… the adjusted Global AntiphosPholipid Syndrome Score (… with aPLs [6], cardiovascular
disease (CVD) being less commonly … In addition, by also including additional cardiovascular risk …

… leading to cardiovascular disease. There is increased cardiovascular mortality in APS. …
anti-inflammatory drugs may help to decrease cardiovascular risk in antiphospholipid syndrome. …

… called secondary antiphospholipid syndrome. … disease, or so-called primary antiphospholipid
syndrome. There is no defined racial predominance for primary antiphospholipid syndrome…

… We suggest that cardiovascular disease prevention guidelines for the general population,
such as those formulated based on the Framingham Heart Study, 75 should play a role in the …

… Several studies reported on the association between antiphospholipid syndrome (APS)
and venous thrombosis. In contrast, little is known about cardiovascular (CV) risk in APS. We …